Skip to main content
SpringerLink
Log in

Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor

  • Chapter
Formulation, Characterization, and Stability of Protein Drugs: Case Histories

Part of the book series: Pharmaceutical Biotechnology ((PBIO,volume 9))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham, J. A., and Klagsbrun, M., 1996, Modulation of wound repair by members of the fibroblast growth factor family, in: The Molecule and Cellular Biology of Wound Repair, 2nd ed. (R. A. F. Clark, ed.), Plenum Press, New York.

    Google Scholar 

  • Abraham, J. A., Mergia, A., Whang, J. L., Tumolo, A., Friedman, J., Hjerrid, K. A., Gospodarowicz, D., and Fiddes, J. C., 1986b, Nucleotide sequence of a bovine clone encoding the angiogenic protein, bFGF, Science 233:545–548.

    Article  CAS  PubMed  Google Scholar 

  • Abraham, J. A., Whang, J. L., Tumolo, A., Friedman, J., Gospodarowicz, S., and Fiddes, J. C., 1986a, Human bFGF: nucleotide sequence and genomic organization, EMBO J. 5:2523–2528.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Adami, M., Dalla Casa, R., Gambini, L., Magrini, R., Mariani, R., and Perrone, G., 1992, Stable pharmaceutical compositions containing a fibroblast growth factor, International Patent Appl. W0 92/01 442.

    Google Scholar 

  • Ahn, S. T., and Mustoe, T. A., 1990, Effects of ischemia on ulcer wound healing: a new model in the rabbit ear, Ann. Plast. Surg. 24:17–23.

    Article  CAS  PubMed  Google Scholar 

  • Ago, H., Kitagawa, Y., Fujishima, A., Matsuura, Y., and Katsube, Y., 1991, Crystal structure of basic fibroblast growth factor at 1.6 A resolution, J. Biochem. 110:360–363.

    Article  CAS  PubMed  Google Scholar 

  • Akiyama, Y., Yoshioka, M., and Kitamori, N., 1993, Stabilized FGF composition and production thereof, U.S. Patent 5189148.

    Google Scholar 

  • Aspenberg, P., Thorngren, K.-G., and Lohmander, L. S., 1991, Fibroblast growth factor increases or inhibits induced bone formation, depending on dose, Transactions 1st Annual Meeting of the European Orthopedic Research Society.

    Google Scholar 

  • Astafieva, I. V., Eberlein, G. A., and Wang, Y. J., 1996, Absolute on-line molecular mass analysis of basic fibroblast growth factor and its multimers by reversed-phase liquid chromatography with multi-angle laser scattering detection, J. Chromatog. A, in press.

    Google Scholar 

  • Broadley, K. N., Aquino, A. M., Hicks, B., Ditesheim, J. A., McGee, G. S., Demetriou, A. A., Woodward, S. C., and Davidson, J. M., 1988, Growth factors bFGF and TGFβ accelerate the rate of wound repair in normal and in diabetic rats, Int. J. Tiss. Reac. 10:345–353.

    CAS  Google Scholar 

  • Burgess, W. H., and Maciag, T., 1989, The heparin-binding (fibroblast) growth factor family of proteins, Annu. Rev. Biochem. 58:575–606.

    Article  CAS  PubMed  Google Scholar 

  • Copeland, R. A., Ji, H., Halfpenny, A. J., Williams, R. W., Thompson, K. C., Herber, W. K., Thomas, K. A., Bruner, M. W., Ryan, J. A., Marquis-Omer, D., Sanyal, G., Sitrin, R. D., Yamazaki, S., and Middaugh, C. R., 1991, The structure of human acidic fibroblast growth factor and its interaction with heparin, Arch. Biochem. Biophys. 239:53–61.

    Article  Google Scholar 

  • Davidson, J., Buckley, A., Woodward, S., Nichols, W., McGee, G., and Demetriou, A., 1988, Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factor, in: Growth Factors and Other Aspects of Wound Healing: Biological and Clinical Implications, Alan R. Liss, New York, pp. 63–75.

    Google Scholar 

  • Davidson, J. M., Klagsbrun, M., Hill, K. E., Buckley, A., Sullivan, R., Brewer, P. S., and Woodward, S. C., 1985, Accelerated wound repair, cell proliferation, and collagen accumulation are produced by a cartilage-derived growth factor, J. Cell Biol. 100:1219–1227.

    Article  CAS  PubMed  Google Scholar 

  • DePonti, R., Torricelli, C., Confalonieri, C., Adami, M., Martini, A., and Lardini, E., 1992, Delivery system for growth factors, U.K. Patent Appl. 2 245 831 A.

    Google Scholar 

  • Eberlein, G. A., Stratton, P. A., and Wang, Y. J., 1994, Stability of rhbFGF as determined by UV spectroscopy, PDA J. Pharm. Sci. Tech. 48:224–230.

    CAS  Google Scholar 

  • Edelman, E. R., Langer, R. S., Klagsburn, M., and Mathiowitz, E., 1989, Controlled release systems containing heparin and growth factors, International Patent Appl. WO/12464.

    Google Scholar 

  • Eriksson, A. E., Cousens, L. S., and Matthews, B. W., 1993, Refinement of the structure of human basic fibroblast growth factor at 1.6 Ã… resolution and analysis of presumed heparin binding sites by selenate substitution, Protein Sci. 2:1274–1284.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Eriksson, A. E., Cousens, L. S., Weaver, L. H., and Matthews, B. W., 1991, Three dimensional structure of human basic fibroblast growth factor, Proc. Natl. Acad. Sci. USA 88:3441–3445.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fiddes, J. C., Hebda, P. A., Hayward, P., Robson, M. C., Abraham, J. A., and Klingbeil, C. K., 1991, Preclinical wound-healing studies with recombinant human basic fibroblast growth factor, Ann. N. Y. Acad. Sci. 638:316–328.

    Article  CAS  PubMed  Google Scholar 

  • Finkenaur, A. L., Cohen, J. M., Shalaby, S. W., Sandoval, E. A., Bezwada, R. S., and Kronenthal, R. L., 1989, Gel formulations containing growth factors, European Patent Appl. 0 312 208.

    Google Scholar 

  • Florkiewicz, R. Z., and Sommer, A., 1989, High molecular weight human angiogenic factors, International Patent Appl. WO/91 06568.

    Google Scholar 

  • Foster, L. C., Thompson, S. A., and Tarnowski, S. J., 1991, Methods and formulations for stabilizing fibroblast growth factor, International Patent Appl. W0/91 15509.

    Google Scholar 

  • Fox, G. M., Schiffer, S. G., Rohde, M. F., Tsai, L. B., Banks, A. R., and Arakawa, T., 1988, Production, biological activity, and structure of recombinant basic fibroblast growth factor and an analog with cysteine replaced by serine, J. Biol. Chem. 263:18452–18458.

    CAS  PubMed  Google Scholar 

  • Fukunaga, K., Hijikata, S., Ishimura, K., Sonoda, R., Irie, T., and Uekama, K., 1994, Aluminium β-cyclodextrin sulphate as a stabilizer and sustained-release carrier for basic fibroblast growth factor, J. Pharm. Pharmacol. 46:168–171.

    Article  CAS  PubMed  Google Scholar 

  • Fukunaga, K., Shigeki, H., Ishimura, K., Ohtani, Y., Kimura, K., Fujii, M., and Hata, Y., 1992, Composition of stabilized fibroblast growth factor, European Patent 0550 035 A2.

    Google Scholar 

  • Gospodarowicz, D., and Cheng, J., 1986, Heparin protects basic and acidic FGF from inactivation, J. Cell Physiol. 128:475–484.

    Article  CAS  PubMed  Google Scholar 

  • Hebda, P. A., Klingbeil, C. K., Abraham, J. A., and Fiddes, J. C., 1990, Basic fibroblast growth factor stimulation of epidermal wound healing in pigs, J. Invest. Dermatol. 95:626–631.

    Article  CAS  PubMed  Google Scholar 

  • Kajio, T., Kawahara, K., and Kato, K., 1992, Stabilization of basic fibroblast growth factor with dextran sulfate, Fed. Europ. Biochem. Soc. 306:243–246.

    Article  CAS  Google Scholar 

  • Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E., and Matsumoto, T., 1994, Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats, Endocrinology 135:774–781.

    Article  CAS  PubMed  Google Scholar 

  • Klingbeil, C. K., Cesar, L. B., and Fiddes, J. C., 1991, Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing, in: Clinical and Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds, Alan R. Liss, New York, pp. 443–458.

    Google Scholar 

  • Koichi, K., Kawahara, K., and Tomoko, K., 1989, Stabilized FGF composition and production thereof, European Patent Appl. 345660 Al.

    Google Scholar 

  • Lee, T.-Y., and Notari, R. E., 1987, Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure, Pharm. Res. 4:98–103.

    Article  CAS  PubMed  Google Scholar 

  • Lindner, V., Lappi, D. A., Baird, A., Majack, R. A., and Reidy, M. A., 1991, Role of bFGF in vascular lesion formation, Circ. Res. 68:106–113.

    Article  CAS  PubMed  Google Scholar 

  • Marks, M. G., Doillon, C., and Silver, F. H., 1991, Effects of fibroblasts and basic fibroblast growth factor or facilitation of dermal wound healing by type 1 collagen matrices, J. Biomed. Mater. Res. 25: 683–696.

    Article  CAS  PubMed  Google Scholar 

  • Matuszewska, B., Keogan, M., Fisher, D. M., Soper, K. A., Hoe, C., Huber, A. C., and Bondi, J. V., 1994, Acidic fibroblast growth factor: evaluation of topical formulations in diabetic mouse wound healing model, Pharm. Res. 11:65–71.

    Article  CAS  PubMed  Google Scholar 

  • McGee, G. S., Davidson, J. M., Buckley, A., Sommer, A., Woodward, S. C., Aquino, A. M., Barbour, R., and Demetriou, A. A., 1988, Recombinant basic fibroblast growth factor accelerates wound healing, . Surg. Res. 45:145–153.

    Article  CAS  Google Scholar 

  • Mustoe, T. A., Pierce, G. F., Morishima, C., and Deuel, T. F, 1991, Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model, J. Clin. Invest. 87:694–703.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ornitz, D. M., Yayon, A., Flanagan, G., Svahn, N., Levi, E., and Leder, P., 1992, Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells, Mol. Cell. Biol. 12:240–247.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Prestrelski, S. J., Arakawa, T., Kenney, W. C., and Byler, D. M., 1991, The secondary structure of two recombinant human growth factors, platelet-derived growth factor and basic fibroblast growth factor, as determined by Fourier-transform infrared spectroscopy, Arch. Biochem. Biophys. 285:111–115.

    Article  CAS  PubMed  Google Scholar 

  • Prestrelski, S. J., Fox, G. M., and Arakawa, T., 1992, Binding of heparin to basic fibroblast growth factor induces a conformational change, Arch. Biochem. Biophys. 293:314–319.

    Article  CAS  PubMed  Google Scholar 

  • Prestrelski, S. J., Tedischi, N., Arakawa, T., and Carpenter, J. F., 1993, Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers, Biophys. J. 65:661–671.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rosenblum, S., Ricci, S. L., Frenkel, S. R., and Aleander, H., 1991, Diffusion of fibroblast growth factor from a calcium sulfate carrier, Proc. Combined Meeting of the Orthopedic Research Societies of USA, Japan, and Canada at Banff, Canada, p. 230.

    Google Scholar 

  • Scheuermann, T. A., Tarnowski, J., and Silverness, K. B., 1992, Method to purify basic fibroblast growth factor, U.S. Patent 5136025.

    Google Scholar 

  • Seno, M., Sasada, R., Iwane, M., Sudo, K., Kurokawa, T., Ito, K., and Igarashi, K., 1988, Stabilizing basic fibroblast growth factor using protein engineering, Biochem. Biophys. Res. Com. 151:701–708.

    Article  CAS  PubMed  Google Scholar 

  • Shadle, P. J., Silverness, K. B., and King, R. S., 1993, Process for purification of basic fibroblast growth factor, U.S. Patent 5331095.

    Google Scholar 

  • Shahrokh, Z., Beylin, I., Eberlein, G., Busch, M., Kang, L., Wong, A., Anderson, C., Blumenthal, D., and Wang, Y. J., 1995, Cellulose cleaving activity from E. coli detected in topical formulations of recombinant proteins, BioPharm. 8:32–38.

    CAS  Google Scholar 

  • Shahrokh, Z., Eberlein, G. A., Buckley, D., Paranandi, M., Aswad, D., Stratton, P. A., Mischak, R., and Wang, Y. J., 1994a, Detection of succinimide in place of aspartate15 as a major degradant of basic fibroblast growth factor, Pharm. Res. 11:936–944.

    Article  CAS  PubMed  Google Scholar 

  • Shahrokh, Z., Eberlein, G. A., and Wang, Y. J., 1994b, Probing the conformation state of protein precipitates by fluorescence spectroscopy, J. Pharm. Biomed. Anal. 12:1035–1041.

    Article  CAS  PubMed  Google Scholar 

  • Shahrokh, Z., Sluzky, V., Stratton, P. R., Eberlein, G. A., and Wang, Y. J., 1994c, Disulfide-Linked Oligomerization of Basic Fibroblast Growth Factor, in ACS Symposium Series 567 on Protein Formulation and Delivery, 1994, American Chemical Society, Washington, DC, Chap. 6.

    Google Scholar 

  • Shahrokh, Z., Stratton, P. A., Eberlein, G. A., and Wang, Y. J., 1994d, Approaches to analysis of aggregates and demonstrating mass balance in pharmaceutical protein (bFGF) formulations, J. Pharm. Sci. 83: 1645–1650.

    Article  CAS  PubMed  Google Scholar 

  • Sluzky, V., Shahrokh, Z., Stratton, P. A., Eberlein, G. A., and Wang, Y. J., 1994, Chromatographic methods for quantitation of native, denatured and aggregated bFGF in solution formulations, Pharm. Res. 11: 485–490.

    Article  CAS  PubMed  Google Scholar 

  • Sommer, A., and Rifkin, D. B., 1989, Interaction of heparin with human basic fibroblast growth factor: protection of angiogenic protein from proteolytic degradation by a glycosaminoglycan, J. Cell. Physiol. 138:215–220.

    Article  CAS  PubMed  Google Scholar 

  • Squires, C. H., Childs, J., Eisenberg, S. P., Polverini, P. J., and Sommer, A., 1988, Production and characterization of human basic fibroblast growth factor from Escherichia coli, J. Biol. Chem. 263: 16297–16302.

    CAS  PubMed  Google Scholar 

  • Stenberg, B. D., Phillips, L. G., Hokanson, J. A., Heggers, J. P., and Robson, M. C., 1991, Effect of bFGF on the inhibition of contraction caused by bacteria, J. Surg. Res. 50:47–50.

    Article  CAS  PubMed  Google Scholar 

  • Tan, E. L., Shah, H. S., Leister, K. J., Kozick, L. M., Pasciak, P., Vanderlaan, R. K., Yu, C.-D., and Patel, B., 1993, Transforming growth factor-α in a semisolid dosage form: Preservative and vehicle selection, Pharm. Res. 10:1238–1242.

    Article  CAS  PubMed  Google Scholar 

  • Thompson, S. A., 1989, Methods to stabilize basic fibroblast growth factor, U.S. Patent 5130418.

    Google Scholar 

  • Thompson, S. A., and Fiddes, J. C., 1992, Chemical characterization of the cysteines of basic fibroblast growth factor, Ann. N.Y. Acad. Sci. 638:78–88.

    Article  Google Scholar 

  • Thompson, S. A., Protter, A. A., BItting, L., Fiddes, J. C., and Abraham, J. A., 1991, Cloning, recombinant expression, and characterization of basicfibroblast growth factor, Meth. Enzymol. 198:96–116.

    Article  CAS  PubMed  Google Scholar 

  • Timasheff, S. N., and Arakawa, T., 1989, in: Stabilization of Protein Structure by Solvents in Protein Structure-A Practical Approach (T. F. Creighton, Ed.), IRL Press, London.

    Google Scholar 

  • Timmins, P., Jackson, I. M., and Wang, Y. J., 1982, Factors affecting captopril stability in aqueous solution, Intl. J.Pharm. 11:329–326.

    Article  CAS  Google Scholar 

  • Tsai, P. K., Volkin, D. B., Dabora, J. M., THompson, K. C., Bruner, M. W., Gress, J. O., Matuszewska, B., Keogan, M., Bondi, J. V., and Middaugh, C. R., 1993, Formulation design of acidic fibroblast growth factor, Pharm. Res. 10:649–659.

    Article  CAS  PubMed  Google Scholar 

  • Ungheri, D., Garofano, L., Battistini, C., Caminati, P., and Mazue, G., 1992, Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent, European Patent Appl, 497 341 A2.

    Google Scholar 

  • Vemuri, S., Beylin, I., Sluzky, V., Stratton, P. A., Eberlein, G. A., and Wang, Y. J., 1994, The stability of bFGF against thermal denaturation, J. Pharm. Pharmacol. 46:481–486.

    Article  CAS  PubMed  Google Scholar 

  • Vemuri, S., Yu, C. T., and Roosdrop, N., 1993, Formulation and stability of recombinant α1-antitrypsin in: Stability and Characterization of Protein and Peptide Drugs (Y. J. Wang and R. Pearlman, eds.), Plenum Press, New York, pp. 263–285.

    Chapter  Google Scholar 

  • Wang, Y. J., 1992, Parental products of proteins and peptides, in: Pharmaceutical Dosage Forms: Parenteral Medications (K. Avis, H. A. Lieberman, and L. Lachman, eds.), Marcel Dekker, New York.

    Google Scholar 

  • Wang, Y. J., and Hanson, M., 1988, Parenteral formulations of proteins and peptides: stability and stabilizer, J. Parenteral Sci. Tech. 42:S1–S26.

    Google Scholar 

  • Watson, E., and Kenney, W. C., 1988, High-performance size-exclusion chromatograph of recombinant derived proteins and aggregated species, J. Chromatogr. 436:289–298.

    Article  CAS  PubMed  Google Scholar 

  • Wu, C.-S. C., Thompson, S. A., and Yang, J. T., 1991, Basic fibroblast growth factor is a β-rich protein J. Protein Chem. 10:427–436.

    Article  CAS  PubMed  Google Scholar 

  • Yamazaki, S., and De Phillips, P. A., 1990, Method for the purification of therapeutically active recombinant acidic fibroblast growth factor, European Patent Appl. 0408 146A2.

    Google Scholar 

  • Zatz, J., Berry, J., and Alderman, D., 1989, Viscosity imparting agents in disperse systems, in: Pharmaceutical Dosage Forms: Disperse Systems (H. Lieberman et al., eds.), Marcel Dekker, New York, pp. 171–204.

    Google Scholar 

  • Zhang, J., Cousens, L. S., Barr, P. J., and Sprang, S. R. 1991, Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β Proc. Natl. Acad. Sci. USA 88:3446–3450.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhu, X., Komiya, H., Chiroin, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T., and Rees, D. C., 1991, Three-dimensional structures of acidic and basic fibroblast growth factors, Science Proc. Natl. Acad. Sci. USA 251:90–93.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Research and Development and Quality Control, Scios Inc., Mountain View, California, 94043, USA

    Y. John Wang, Sriram Vemuri & Mark Busch

  2. Department of Research and Development, Genentech Inc., South San Francisco, California, 94080, USA

    Zahra Shahrokh

  3. Research and Development, Matrix Pharmaceutical Inc., Menlo Park, California, 94025, USA

    Gert Eberlein

  4. Development, Alza Corporation, Palo Alto, California, 94303, USA

    Irina Beylin

Authors
  1. Y. John Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zahra Shahrokh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sriram Vemuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gert Eberlein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irina Beylin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mark Busch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Megabios Corporation, Burlingame, California, USA

    Rodney Pearlman

  2. Scios Nova, Inc., Mountain View, California, USA

    Y. John Wang

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Wang, Y.J., Shahrokh, Z., Vemuri, S., Eberlein, G., Beylin, I., Busch, M. (2002). Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor. In: Pearlman, R., Wang, Y.J. (eds) Formulation, Characterization, and Stability of Protein Drugs: Case Histories. Pharmaceutical Biotechnology, vol 9. Springer, Boston, MA. https://doi.org/10.1007/0-306-47452-2_2

Download citation

  • DOI: https://doi.org/10.1007/0-306-47452-2_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45332-8

  • Online ISBN: 978-0-306-47452-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation